# Team:Tokyo Tech/Project/Artificial Cooperation System

(Difference between revisions)
 Revision as of 23:44, 27 October 2010 (view source)Kitano (Talk | contribs)← Older edit Revision as of 23:47, 27 October 2010 (view source)Kitano (Talk | contribs) Newer edit → Line 38: Line 38:
3 Artificial Cooperation System 3 Artificial Cooperation System - =Artificial Cooperation System= =Artificial Cooperation System= Line 122: Line 121: [[IMAGE:Tokyotech cellA circuit.png|400px|left|thumb|Fig3-0-2.Genetic circuit in cell A]] [[IMAGE:Tokyotech cellA circuit.png|400px|left|thumb|Fig3-0-2.Genetic circuit in cell A]] [[IMAGE:Tokyotech cellB corcuit.png|400px|left|thumb|Fig3-0-3.Genetic circuit in cell B ]] [[IMAGE:Tokyotech cellB corcuit.png|400px|left|thumb|Fig3-0-3.Genetic circuit in cell B ]] + + + + Line 163: Line 166: - Normal + Normal [[IMAGE:tokyotech_normal.jpg|400px|left|thumb|Fig3-0-4. Normal condition]] [[IMAGE:tokyotech_normal.jpg|400px|left|thumb|Fig3-0-4. Normal condition]] Line 201: Line 204:

- when Cell A is dying + when Cell A is dying [[IMAGE:tokyotech_cell A is dyng.jpg|400px|left|thumb|Fig 3-0-6. Cell A is dying.]] [[IMAGE:tokyotech_cell A is dyng.jpg|400px|left|thumb|Fig 3-0-6. Cell A is dying.]] Line 238: Line 241: - when Cell B tries to rescue Cell A + when Cell B tries to rescue Cell A [[IMAGE:tokyotech_rescue.png|400px||left|thumb|Fig 3-0-8. Cell B is trying to rescue cell A]] [[IMAGE:tokyotech_rescue.png|400px||left|thumb|Fig 3-0-8. Cell B is trying to rescue cell A]]

## Revision as of 23:47, 27 October 2010

iGEM Tokyo Tech 2010 "E.coli with Humanity"

3 Artificial Cooperation System                    -YOU ARE HERE!- 3-1 lux activation/repression promoter 3-2 resistance gene activation device 3-3 luxI Assay 3-4 modeling 1 Graphic abstract 2 Apple reporter 2-1 Color 2-2 Fragrance 4 Wolf coli overview 4-1 New seriesof PompC 4-2 lacIM1 for band-detect network 4-3 Wolf coli system

3 Artificial Cooperation System

# Abstract

We built Artificial Cooperation System to engineer E.coli with humanity. In this system quorum sensing system and chloramphenicol resistance protein generator activated by LuxR are very important. First, we constructed and characterized several promoters regulated by LuxR and 3OC6HSL. We designed and constructed a new LuxR repression promoter. Also, we characterized the functions of a LuxR repression promoter and a LuxR activation promoter in the registry. Second, we constructed a new chloramphenicol resistance protein generator which is regulated by LuxR activation promoter. We confirmed that the cell with the chloramphenicol resistance protein generator can survive under high concentration of chloramphenicol when 3OC6HSL exists. Third, we confirmed that LuxI can produce sufficient 3OC6HSL to activate chloramphenicol resistance gene. Forth, we confirmed the feasibility of Artificial Cooperation System from simulation and experimental data.

fig.3-1-1 luxR activation promoter assay (worked by Kitano Shohei & Eriko Uchikoshi)
fig.3-1-3 luxR repression promoter assay (worked by Shohei Kitano & Eriko Uchikoshi)

Fig3-2-1 Chloramphenicol resistance device. This work done by Yusuke Kaneta
Fig3-3-1 LuxI and LuxR activation promoter assay. This work done by Eriko Uchikoshi and Shohei Kitano

# Introduction

## What’s Artificial Cooperation System?

Artificial Cooperation System was built to engineer E. coli that behaves kindly and have sympathy. This system consists of two types of cells. In normal conditions, they are competitors for survival. While in critical conditions, such that one is dying, another cell would notice the crisis of dying cell and help her. This is a summary of the Artificial Cooperation System.

Fig 3-0-1.They are competitors. 2.One is dying, another cell notices it. 3.The healthy cell rescues the dying cell. 4. The dying cell recovers and she gives "Apples" as expression of appreciation

## Genetic Circuit

We designed the following circuit. In Artificial Cooperation System, there are two types of E. coli, Cell A and Cell B. Cell A has resistance to kanamycin and Cell B has resistance to chloramphenicol originally. In cell A (Fig 3-0-2), production of LasI is repressed by LuxR/3OC6HSL complex and chloramphenicol resistance gene is activated by LuxR/3OC6HSL complex. In cell B (Fig3-0-3), production of LuxI is repressed by LasR/3OC12HSL complex and kanamycin resistance gene is activated by LasR/3OC12HSL complex. This means that 3OC12HSL produced by cell A and 3OC6HSL produced by cell B indirectly repress each other’s production. On the other hand, 3OC12HSL activates resistance gene of cell B and 3OC6HSL activates resistance gene of cell A. Apple gene is composed of crtEBIYZW and MpAAT1. This expresses only when the cell is rescued and recovered.

Fig3-0-2.Genetic circuit in cell A
Fig3-0-3.Genetic circuit in cell B

Pcon: constitutive promoter.
Plux act: promoter activated by LuxR and 3OC6HSL. We call this promoter luxR activation promoter.
Plux rep: promoter repressed by LuxR and 3OC6HSL. We call this promoter luxR repression promoter.
Plas act: promoter activated by LasR and 3OC12HSL. We call this promoter lasR activation promoter.
Plas rep: promoter repressed by LasR and 3OC12HSL. We call this promoter lasR repression promoter.
lasI: enzyme repressed by LuxR and 3OC6HSL. We call this promoter LuxR repression promoter.
luxI: enzyme repressed by LasR and 3OC12HSL. We call this promoter LasR repression promoter.

Normal

Fig3-0-4. Normal condition
Fig3-0-5. Normal condition

In normal situation, Cell A and Cell B are competitors and recognize each other by using quorum sensing. First, LasI protein in Cell A produces 3OC12HSL. Second, these signal molecules diffuse through cell membranes and bind to LasR protein in Cell B. Third, LasR/3OC12HSL complex represses the production of LuxI protein. Similarly in cell B, LuxI protein produces 3OC6HSL. These signal molecules diffuse through cell membranes and bind to LuxR protein in Cell A. LuxR/3OC6HSL complex represses the production of LasI protein. Although Cell A and Cell B have chloramphenicol and kanamycin resistance gene respectively, they don’t express in this situation. This is because the concentration of 3OC12HSL and 3OC6HSL is too low to activate the expressions of kanamycin resistance gene and chloramphenicol resistance gene, respectively.

when Cell A is dying

Fig 3-0-6. Cell A is dying.
Fig 3-0-7. Cell A is dying.

As we mentioned, originally Cell A has a resistance gene against kanamycin and does not have that against chloramphenicol. On the other hand, Cell B has resistance to chloramphenicol and doesn’t have resistance to kanamycin. Therefore, the addition of chloramphenicol only decreases the number of Cell A. It means that 3OC12HSL decreases. It also results in the decrease of LasR/3OC12HSL complex that repress the expression of LasI in Cell B. By this process, Cell B notices that Cell A is dying and tries to rescue it.

when Cell B tries to rescue Cell A

Fig 3-0-8. Cell B is trying to rescue cell A
Fig 3-0-9. Cell B is trying to resucue cell A

Fig 3-0-10. Cell A is rescued by cell B.
Fig 3-0-11. Cell A is rescued by cell B.

As we mentioned, the expression of luxI is repressed by LasR/3OC12HSL complex. Therefore, the decrease of 3OC12HSL/LasR complex causes the overexpression of luxI and the increase of 3OC6HSL. This results in the expression of chloramphenicol resistance gene in the Cell A. Consequently, the Cell A is recovered and begins to produce the apple reporters in return!

# Result

In order to make the Artificial Cooperation System, we constructed and characterized several important parts and devices. First we characterized LuxR repression promoter R0061 and activation promoter R0062, both of which are existing parts. Second, we designed and characterized a new LuxR repression promoter K395008. Third, we designed and characterized a NEW BioBrick device K395162, a chloramphenicol resistance generator, which is activated by a LuxR activation promoter. Forth, we confirmed that LuxI can produce sufficient AHL to help dying cell. Finally, we simulated our Artificial Cooperation System and confirmed the feasibility of our system.

## LuxR repression promoter and activation promoter

We characterized LuxR repression promoters and activation promoters, which play important roles in the Artificial Cooperation System. The following figures are the result of experiments. Fig3-1-1 shows that under the regulations by R0062 (LuxR activation promoter), gfp expression was activated in the presence of 3OC6HSL. Fig3-1-3 shows that under the regulations by R0061 and K395008, gfp expressions were repressed in the presence of 3OC6HSL. Also, for realization of the Artificial Cooperative System work, the strength and the threshold of these promoters are so important. Thus we tried tuning promoters by changing sequence of consensus -35/-10 and lux box. (See more…)

fig.3-1-1 luxR activation promoter assay (worked by Kitano Shohei & Eriko Uchikoshi)
fig.3-1-3 luxR repression promoter assay (worked by Shohei Kitano & Eriko Uchikoshi)

## Chloramphenicol resistance geneator activated by LuxR

We succeeded in construction and characterization of a NEW Biobrick device of a chloramphenicol resistance (CmR) generator (BBa_K395162) which is activated by LuxR activation promoter. Fig 3-2-1 shows that in the presence of 3OC6HSL, the device is activated and as a result the cell was able to survive under high chloramphenicol concentration (750 ug/ml). (See more…)

Fig3-2-1 Chloramphenicol resistance device. This work done by Yusuke Kaneta

## LuxI can produce sufficient 3OC6HSL to activate LuxR activation promoter

We constructed a new LuxI generator (BBa_K395146) and characterized its function. By combining I14032 (PlacIq) and K092400 (rbs-luxI-ter), we constructed K395146. Then we confirmed that the cell with K395146 produced the sufficient amount of 3OC6HSL to activate LuxR activation promoter (R0062) (See more…)

Fig3-3-1 LuxI and LuxR activation promoter assay. This work done by Eriko Uchikoshi and Shohei Kitano

## Mathematical modeling

In order to confirm the feasibility of the Artificial Cooperation System, we simulated the system under typical four experimental conditions. First, when the system worked and any antibiotics did not exist, cell A and cell B in the system showed no difference of growth (Fig.3-0-2). Second, when the system did not work and chloramphenicol existed, the number of cell A decreased while the number of cell B increased (Fig.3-0-3). Third, when the system worked and chloramphenicol existed, the number of cell A increased after temporal decline (Fig.3-0-4), which means it was rescued by Artificial Cooperation System. Fourth, in the contrast, when the system worked and kanamycin existed, the number of cell B increased after temporal decline (Fig.3-0-5). From the above results, the feasibility of the Artificial Cooperation System was confirmed.(See more…)

Fig3-0-2 Simulation result in absence of antibiotics. This work done by Shohei Kitano
Fig3-0-3 Simulation result without Artificial Cooperation System. This work done by Shohei Kitano

Fig3-0-4 Simulation result in the presence of chloramphenicol. This work done by Shohei Kitano
Fog3-0-5 Simulation result in the presence of kanamycin. This work done by Shohei Kitano

# Conclusion

We succeeded in constructing two new BioBrick, LuxR repression promoter (K395008) and chloramphenicol resistance gene generator activated by LuxR and 3OC6HSL. We characterized existing LuxR repression promoter and LuxR activation promoter in the registry. From the experimental data and simulation result, we confirmed the feasibility of the Artificial Cooperation System, E. coli with humanity.